Ontology highlight
ABSTRACT: Background
Invasive lobular carcinoma (ILC) has lower response rates to neoadjuvant chemotherapy (NAC) than invasive ductal carcinoma. While ILC often has low-risk biology, there is a high-risk subset within this heterogeneous tumor type. We compared surgical treatment and response rates by histology in I-SPY2, a multicenter NAC trial.Methods
We evaluated 1329 patients with stage II-III breast cancer and high-risk 70-gene assay. Patients with classic, pleomorphic, or mixed lobular/ductal histology were included in the lobular cohort. We evaluated rates of mastectomy, positive margins, axillary dissection, and conversion from clinical node-positive (cN+) to pathologic node-negative (ypN-) status after NAC.Results
Overall, 124 patients (9.3%) had lobular histology, wi
SUBMITTER: Mukhtar RA
PROVIDER: S-EPMC12494636 | biostudies-literature | 2025 Oct
REPOSITORIES: biostudies-literature